RedChip Companies

RedChip is the world leader in investor relations, financial media, and research for microcap and small-cap stocks. RedChip has helped hundreds of companies achieve their capital markets goals and has been ranked by Inc. Magazine as one of the fastest growing privately held investor relations firms in the U.S. #finance #capitalmarkets #investorrelations

📢 BullFrog AI (Nasdaq: BFRG) Investor Webinar on April 23 — Unlocking the Future of Drug Development with AI BullFrog AI's leadership invites investors to a live webinar on Wednesday, April 23 at 4:15 PM ET, showcasing how its proprietary bfLEAP® platform and BullFrog Data Networks® are reshaping the biotech landscape. 💡 Why This Matters to Investors: - Massive Market Need: With only ~12% of drugs reaching approval from Phase 1, BullFrog AI's AI-driven insights address a $200B+ R&D challenge. - Disruptive Technology: bfLEAP® reveals hidden patterns in high-dimensional datasets, improving target discovery and trial outcomes. - Dual Growth Strategy: Revenue-generating platform + drug asset development + prestigious partners (e.g., J. Craig Venter Institute). Don’t miss this opportunity to learn how BullFrog AI is helping biopharma companies do more with less—while tackling inefficiencies across the drug development pipeline. 🔗 https://lnkd.in/eVt344HH Lieber Institute for Brain Development Biotechnology Biotechnology News #BFRG #BiotechInvesting #AIinHealthcare #DrugDiscovery #InvestorWebinar #HealthcareAI

🚨 Aptevo Therapeutics (Nasdaq: APVO) Reports 90% Remission* in AML Trial In its RAINIER Phase 1b/2 trial, Aptevo Therapeutics Inc reported 9 out of 10 patients achieved remission when treated with mipletamig + venetoclax + azacitidine—a 90% remission rate, outperforming the ~66% rate typically seen with the doublet (venetoclax + azacitidine) alone. (*Remission = complete remission (CR) and, complete remission with blood markers that have not yet recovered (CRi). 💡 Why It Matters: • Consistent Efficacy – Mirrors results from prior Phase 1 (R/R AML) • High Unmet Need – AML treatments remain limited • Momentum Building – Cohort 2 enrollment is active; next data readout could be pivotal 🔗 Learn More: https://lnkd.in/eQpU7RTk Lymphoma, Leukemia & Myeloma Congress Biotechnology Biotechnology News #BiotechStocks #AML #ClinicalTrials #CancerResearch #Aptevo #APVO #Oncology

💰 Better Choice Company (NYSE:BTTR) Strengthens Balance Sheet with $8.1M Deal for Halo Asia Business Better Choice sold its Halo Asia operations to CZC Company LTD for $8.1 million in total proceeds, including $6.5 million in upfront cash—equivalent to $3.34 per share. The transaction also includes a 5-year royalty agreement with minimum revenue guarantees. 📦 Core Operations Remain: Better Choice retains full control of North American and non-Asia international operations, sharpening focus on its primary health & wellness markets. 💡 Why This Matters to Investors: 💵 Boosts liquidity with significant upfront cash 🔄 Adds recurring royalty income through 2029 🎯 Refocuses company strategy on high-growth core markets 🛠️ Unlocks flexibility for future capital deployment—potential buybacks, dividends, or diversification 🔗 https://lnkd.in/ed_EpvKM Mergers & Acquisitions (M&A) Veterinary Practice #BTTR #PetWellness #InvestorNews #ShareholderValue #AssetOptimization #PetIndustry

🤖 VSee Health (Nasdaq: VSEE) Introduces AI-Powered Telenursing Robotics to Cut Hospital Costs VSee has unveiled its new Telenursing Robotics solution, targeting a 3–5% reduction in hospital nursing expenses—a major line item accounting for ~60% of hospital operating costs. 💡 Why This Matters to Investors: - Cost Reduction & Efficiency: Hospitals could save millions annually, while improving patient satisfaction and throughput. - Strategic Pilots Underway: Clinical partnerships and research-driven pilots now launching with select hospitals to validate real-world ROI. - Massive Market Opportunity: Addresses a $787B digital health market with a scalable, AI-driven solution. 📄 https://lnkd.in/ep-vFe6C MedTech Dive Telemedicine #DigitalHealth #HealthcareInnovation #AI #Telenursing #HospitalEfficiency #MicroCapStocks #Investing #FinancialNews

🛡️ Gorilla Technology (Nasdaq: GRRR) Files Lawsuit to Confront False Allegations and Protect Shareholders Gorilla Technology Group has filed a lawsuit against Culper Research and its founder over what it calls false, misleading, and defamatory statements made in a short report. The suit seeks compensatory and punitive damages. 💡 Why This Matters to Investors: - Protecting Shareholder Value: Gorilla alleges the report artificially depressed its stock price and damaged business credibility. - Strong Corporate Response: This legal move signals Gorilla's intent to aggressively safeguard its operations, partners, and investors from market manipulation. - Restoring Market Confidence: Management reaffirms its commitment to transparency, integrity, and holding bad actors accountable. 📄 https://lnkd.in/eMNa-mBB #TechInvesting #SmartCities #MarketIntegrity #FinancialNews #GRRR #InvestorProtection #NASDAQStocks

Sanofi Asthma Drug Misses Primary Goal Investors are buzzing about Connect Biopharma (Nasdaq: CNTB) as it traded 50x average volume on this news! Under the new leadership of Barry Quart (CEO) and David Szerkeres (President), Connect Biopharma is making waves with their groundbreaking Phase 2 trials in acute asthma and COPD. Results from these trials could be game-changing for patients and investors alike. The annual U.S. market includes ~1 million asthma and ~1.3 million COPD patients experiencing severe exacerbations requiring urgent ER treatment. 📰 https://lnkd.in/e_BD5iDK Biotechnology Biotechnology News Asthma.net #CNTB #Asthma #COPD #Biotech #ClinicalTrials #RespiratoryCare #Investing #finance

US critical minerals race heats up as China halts rare earth exports. Antimony—critical for defense, semis, and energy storage—is now nearly $60K/ton. The U.S. has zero domestic production. One overlooked name?  Nova Minerals Limited (Nasdaq: NVA). They're sitting on ~9.9Moz gold + high-grade antimony at their Estelle project in Alaska. Gold + critical minerals on U.S. soil = opportunity. 📰 https://lnkd.in/eG9iZwgJ Mines and Money S&P Global Commodity Insights Commodities: Iron, Steel, Copper, Metal, Gold, Silver, Rice, Wheat, Oil, Gas, Coffee, Cotton, Sugar #NovaMinerals #RedChipClient #RedChat #preciousmetals #antimony #Alaska #goldrush #Gold #MiningStocks

🎤 VENU (NYSE American: VENU) Adds Live Nation Veteran to Leadership Team Victor Sutter, a veteran of Live Nation Entertainment and hospitality visionary, joins VENU as Executive VP of Operations to spearhead operational excellence across the company’s growing portfolio of upscale live entertainment venues. 💡 Why This Matters to Investors: • Proven Expertise: Led operations for iconic brands like House of Blues and Brooklyn Bowl, serving over 3M fans annually. • Strategic Growth: Will elevate VENU's culinary programs, premium offerings, and hospitality to fuel revenue and margin growth. • Highly Experienced Team: Sutter is the third high-profile senior executive added in six months. 🔗 https://lnkd.in/ecrthG_2 Troy Aikman EIGHT Elite Light Lager AEG #RedChip #RedChat #VENU #LiveEntertainment #Investing #SmallCapStocks #Hospitality

📢 ASP Isotopes (Nasdaq: ASPI) Strengthens Leadership Team with Latest Board Changes ASP Isotopes has appointed veteran South African executive Sipho Maseko—former CEO of Telkom SA and MD of Vodacom SA—to its Board of Directors, strengthening its leadership as it expands advanced isotope and nuclear fuel initiatives. 💼 Key Leadership Moves: - Maseko brings decades of executive experience and deep ties to South Africa’s industrial and energy sectors. - Dr. Hendrik Strydom, PhD, transitions from ASP Isotopes' board to Quantum Leap Energy (QLE), focusing on advanced nuclear fuels like HALEU and Lithium-6. 🔄 Why This Matters for Investors: - ASP Isotopes plans to spin out QLE as a separate public company in 2H 2025, enabling focused growth in nuclear fuels while ASP drives innovation in medical and industrial isotopes. The board realignment supports regulatory and capital planning efforts related to the spinoff. 📄 Read the Full Announcement 🔗 https://lnkd.in/eZ7_ZwC5 Nuclear for Climate Semiconductor Nation - Campus Connect Nuclear #RedChip #RedChat #ASPIsotopes #NuclearEnergy #Isotopes #Sustainability #Investing #GreenTech